Accès gratuit
Med Sci (Paris)
Volume 29, Numéro 1, Janvier 2013
Page(s) 47 - 55
Section M/S Revues
Publié en ligne 25 janvier 2013
  1. Knobel DL, Cleaveland S, Coleman PG, et al. Re-evaluating the burden of rabies in Africa and Asia. Bull World Health Organ 2005 ; 83 : 360–368. [PubMed] [Google Scholar]
  2. Davis PL, Bourhy H, Holmes EC. The evolutionary history and dynamics of bat rabies virus. Infect Genet Evol 2006 ; 6 : 464–473. [CrossRef] [PubMed] [Google Scholar]
  3. Dacheux L, Larrous F, Mailles A, et al. European bat Lyssavirus transmission among cats, Europe. Emerg Infect Dis 2009 ; 15 : 280–284. [CrossRef] [PubMed] [Google Scholar]
  4. Kuzmin IV, Shi M, Orciari LA, et al. Molecular inferences suggest multiple host shifts of rabies viruses from bats to mesocarnivores in Arizona during 2001–2009. PLoS Pathog 2012 ; 8 : e1002786. [CrossRef] [PubMed] [Google Scholar]
  5. Leslie MJ, Messenger S, Rohde RE, et al. Bat-associated rabies virus in skunks. Emerg Infect Dis 2006 ; 12 : 1274–1277. [CrossRef] [PubMed] [Google Scholar]
  6. De Benedictis P, Gallo T, Iob A, et al. Emergence of fox rabies in north-eastern Italy. Euro Surveill 2008 ; 13 : 19033. [PubMed] [Google Scholar]
  7. Lardon Z, Watier L, Brunet A, et al. Imported episodic rabies increases patient demand for, physician delivery of antirabies prophylaxis. PLoS Negl Trop Dis 2010 ; 4 : e723. [CrossRef] [PubMed] [Google Scholar]
  8. Meynard JB, Flamand C, Dupuy C, et al. First human rabies case in French Guiana, 2008: epidemiological investigation and control. PLoS Negl Trop Dis 2012 ; 6 : e1537. [CrossRef] [PubMed] [Google Scholar]
  9. Bourhy H, Cowley JA, Larrous F, et al. Phylogenetic relationships among rhabdoviruses inferred using the L polymerase gene. J Gen Virol 2005 ; 86 : 2849–2858. [CrossRef] [PubMed] [Google Scholar]
  10. Holmes EC, Woelk CH, Kassis R, Bourhy H. Genetic constraints and the adaptive evolution of rabies virus in nature. Virology 2002 ; 292 : 247–257. [CrossRef] [PubMed] [Google Scholar]
  11. Prehaud C, Wolff N, Terrien E, et al. Attenuation of rabies virulence: takeover by the cytoplasmic domain of its envelope protein. Sci Signal 2010 ; 3 : ra5. [CrossRef] [PubMed] [Google Scholar]
  12. Tuffereau C, Leblois H, Bénéjean J, et al. Arginine or lysine in position 333 of ERA and CVS glycoprotein is necessary for rabies virulence in adult mice. Virology 1989 ; 172 : 206–212. [CrossRef] [PubMed] [Google Scholar]
  13. Schumacher CL, Coulon P, Lafay F, et al. SAG-2 oral rabies vaccine. Onderstepoort J Vet Res 1993 ; 60 : 459–462. [PubMed] [Google Scholar]
  14. Larrous F, Gholami A, Mouhamad S, et al. Two overlapping domains of a lyssavirus matrix protein that acts on different cell death pathways. J Virol 2010 ; 84 : 9897–9906. [CrossRef] [PubMed] [Google Scholar]
  15. Vidy A, El Bougrini J, Chelbi-Alix MK, Blondel D. The nucleocytoplasmic rabies virus P protein counteracts interferon signaling by inhibiting both nuclear accumulation and DNA binding of STAT1. J Virol 2007 ; 81 : 4255–4263. [CrossRef] [PubMed] [Google Scholar]
  16. Assenberg R, Delmas O, Morin B, et al. Genomics and structure/function studies of Rhabdoviridae proteins involved in replication and transcription. Antiviral Res 2010 ; 87 : 149–161. [CrossRef] [PubMed] [Google Scholar]
  17. Crepin P, Audry L, Rotivel Y, et al. Intravitam diagnosis of human rabies by PCR using saliva and cerebrospinal fluid. J Clin Microbiol 1998 ; 36 : 1117–1121. [PubMed] [Google Scholar]
  18. Dacheux L, Reynes JM, Buchy P, et al. A reliable diagnosis of human rabies based on analysis of skin biopsy specimens. Clin Infect Dis 2008 ; 47 : 1410–1417. [CrossRef] [PubMed] [Google Scholar]
  19. Maier T, Schwarting A, Mauer D, et al. Management and outcomes after multiple corneal and solid organ transplantations from a donor infected with rabies virus. Clin Infect Dis 2010 ; 50 : 1112–1119. [CrossRef] [PubMed] [Google Scholar]
  20. Srinivasan A, Burton EC, Kuehnert MJ, et al. Transmission of rabies virus from an organ donor to four transplant recipients. N Engl J Med 2005 ; 352 : 1103–1111. [CrossRef] [PubMed] [Google Scholar]
  21. Hemachudha T, Laothamatas J, Rupprecht CE. Human rabies: a disease of complex neuropathogenetic mechanisms and diagnostic challenges. Lancet Neurol 2002 ; 1 : 101–109. [CrossRef] [PubMed] [Google Scholar]
  22. Hemachudha T, Wacharapluesadee S, Mitrabhakdi E, et al. Pathophysiology of human paralytic rabies. J Neurovirol 2005 ; 11 : 93–100. [CrossRef] [PubMed] [Google Scholar]
  23. Hemachudha T, Wacharapluesadee S, Laothamatas J, Wilde H. Rabies. Curr Neurol Neurosci Rep 2006 ; 6 : 460–468. [CrossRef] [PubMed] [Google Scholar]
  24. Jackson AC. Rabies: new insights into pathogenesis and treatment. Curr Opin Neurol 2006 ; 19 : 267–270. [CrossRef] [PubMed] [Google Scholar]
  25. WHO. Rabies vaccines: position paper. Wkl Epidemiol Rec 2010 ; 32 : 309–320. [Google Scholar]
  26. Quiambao BP, Dytioco HZ, Dizon RM, et al. Rabies post-exposure prophylaxis in the Philippines: health status of patients having received purified equine F(ab’)(2) fragment rabies immunoglobulin (Favirab). PLoS Negl Trop Dis 2008 ; 2 : e243. [CrossRef] [PubMed] [Google Scholar]
  27. Rupprecht CE, Briggs D, Brown CM, et al. Use of a reduced (4-dose) vaccine schedule for postexposure prophylaxis to prevent human rabies: recommendations of the advisory committee on immunization practices. MMWR Recomm Rep 2010 ; 59 : 1–9. [Google Scholar]
  28. Dacheux L, Delmas O, Bourhy H. Human rabies encephalitis prevention and treatment: progress since Pasteur’s discovery. Infect Disord Drug Targets 2011 ; 11 : 251–299. [CrossRef] [PubMed] [Google Scholar]
  29. Willoughby RE, Jr, Tieves KS, Hoffman GM, et al. Survival after treatment of rabies with induction of coma. N Engl J Med 2005 ; 352 : 2508–2514. [CrossRef] [PubMed] [Google Scholar]
  30. Willoughby RE Jr., A cure for a rabies? Sci Am 2007 ; 296 (4) : 88–95. [CrossRef] [PubMed] [Google Scholar]
  31. Gautret P, Shaw M, Gazin P, et al. Rabies postexposure prophylaxis in returned injured travelers from France, Australia, and New Zealand: a retrospective study. J Travel Med 2008 ; 15 : 25–30. [CrossRef] [PubMed] [Google Scholar]
  32. Dodet B. The fight against rabies in Africa: From recognition to action. Vaccine 2009 27 : 5027–5032. [CrossRef] [PubMed] [Google Scholar]
  33. Bakker AB, Python C, Kissling CJ, et al. First administration to humans of a monoclonal antibody cocktail against rabies virus: safety, tolerability, and neutralizing activity. Vaccine 2008 ; 26 : 5922–5927. [CrossRef] [PubMed] [Google Scholar]
  34. Both L, Banyard AC, van Dolleweerd C, et al. Passive immunity in the prevention of rabies. Lancet Infect Dis 2012 ; 12 : 397–407. [CrossRef] [PubMed] [Google Scholar]
  35. Dreyfus C. Vers un vaccin universel contre la grippe ? Med Sci (Paris) 2013 ; 29 : 22–25. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]

Les statistiques affichées correspondent au cumul d'une part des vues des résumés de l'article et d'autre part des vues et téléchargements de l'article plein-texte (PDF, Full-HTML, ePub... selon les formats disponibles) sur la platefome Vision4Press.

Les statistiques sont disponibles avec un délai de 48 à 96 heures et sont mises à jour quotidiennement en semaine.

Le chargement des statistiques peut être long.